Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2)
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
- To assess the efficacy of R348 Ophthalmic Solutions administered for 12 weeks to
subjects evaluated by objective and subjective measures.
- To investigate the safety and tolerability of R348 Ophthalmic Solutions administered for
12 weeks to subjects.